Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (61)	5/21/2001 5:05:25 PM
From: Jibacoa	Read Replies (3) \| Respond to of 544

XOMA: Has been trading on "double-tops" and "triple-tops" for some time.<g> The nearest resistance is now today's "triple top" with the intra-day Hs at 11.05 AM, 2.55PM and 3.50PM at the 11.50 level. The heaviest volumes (on a 5 minute basis) were around 11AM, apparently on the up-side(107,600)(up from 11.34 to 11.40); 3.50PM also somewhat to the up-side, but meeting resistance at the 11.50 level (107,000)(11.40 to 11.47)and the 123,700 volume near the close, which was definitely downwards (11.47 to 11.36) Today's total volume was 1,503,200(about 5x the recent average) and it was up 4.22% for the day. Not bad.<g>( I am satisfied if I can average 3% a week).<g> After the aforementioned 11.50 resistance the next hurdle is the April 30 H at 12.10 before it could think of testing the January 24-January 25 double-top at 13.87 Next in line would be the November double-top at the 15.25 level (that was slightly above the October H at 15.12 <g>)and then the March 2000 H at 16 As far as "support levels" the nearest ones are 9.75 before getting to the stronger looking 8.60 (from April) Revenues for past 3 years have been unimpressive (6.3M, 2.4M & 6.7M)but yearly loss has been declining.<g.(-1.56 to -0.87 to -0.45)and the current estimate is -0.42 According to their announcement last week they are going to start litigation with Biosite concerning the license agreements related to the bacterial expression of antibodies. They reportedly are receiving some license fee payments from BAX & ONXX The insiders only hold 3% and there have been more sellers than buyers lately.Institutions hold 36% and they reportedly have been buying. The company has a negative book value of -0.23 although they apparently have close to $0.50/share of cash. The overall chart is not impressive (and there are a lot of more better looking ones.<g>)The stock has to close significantly above 15 (at least 18 or as much as 23) for it to signal that it has a strong intention to challenge the 1991 H around 34.<g> I am not sure if that short summary will be of any help, but if not sufficient you can always wait for Paula's answer. RAGL Bernard

To: aknahow who wrote (61)	5/21/2001 11:53:59 PM
From: XenaLives	Read Replies (1) \| Respond to of 544

First, I want to make it clear that I started this thread to learn, not to hold myself out as a technical guru :) Still I will venture an opinion. I haven't mastered some of the more classic analysis techniques, but in this market I have found that volatility is very important. It looks like the boat started rocking again today and if I were invested in the stock that would make me nervous. I am seeing repeated patterns of dragging stocks down to trigger stops and then cranking them back up again. I think there is a conscious effort to exploit the fear that has been conditioned into the retail investor by the recent market volatility. I just got whacked good in IMGN - the news was too good and I thought NO WAY would they be able to pull it down. I was wrong. I am constantly amazed at the inability of the retail investor to read and comprehend a press release. Good news comes out, the stock is shorted down rapidly, and the hordes panic. A few days later the news sinks in and they come charging back, buying at higher prices. Good luck!